Projects funded by the NCN

Development of optimization methods for dose selection of analgesic drugs used as a combination drug therapy in neuropat...

Call: OPUS 9 , Panel: NZ7

Principal investigator: dr hab. Kinga Sałat

Uniwersytet Jagielloński - Collegium Medicum, Uniwersytet Jagielloński - Collegium Medicum, Wydział Farmaceutyczny

The role of kynurenine pathway in neurophatic pain in view of innovative treatment approaches

Call: SONATA 9 , Panel: NZ4

Principal investigator: dr Ewelina Rojewska

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Functionalized amino acids - inibitors of GABA uptake with antianalgetic activity

Call: OPUS 8 , Panel: NZ7

Principal investigator: dr Paula Zaręba

Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

Synthesis, physicochemical and pharmacological properties of new amide derivatives of 3,3-disubstituted pyrrolidine-2,5-...

Call: OPUS 6 , Panel: NZ7

Principal investigator: prof. Jolanta Obniska

Uniwersytet Jagielloński Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

Neuronal and nonneuronal mechanisms of Bont/A effects in neuropathic pain development - behavioral and biochemical studi...

Call: HARMONIA 5 , Panel: NZ4

Principal investigator: dr hab. Joanna Mika

Instytut Farmakologii PAN

Activation of endogenous pronociceptive mechanisms of opioid system as an important factors in the development of neurop...

Call: MAESTRO 3 , Panel: NZ4

Principal investigator: prof. Barbara Przewłocka

Instytut Farmakologii PAN

Understanding the contribution of immunoproteasome activation to the neuropathic pain development.

Call: OPUS 25 , Panel: NZ7

Principal investigator: dr Natalia Małek-Chudzik

Politechnika Wrocławska

The role of simultaneous and individual modulation of μ-opioid, sigma-1 and histamine H3 receptors as a new therapeutic ...

Call: OPUS 23 , Panel: NZ7

Principal investigator: dr Katarzyna Szczepańska

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

New strategies in the pharmacotherapy of neuropathic pain based on modulation of the chemokine system and its influence ...

Call: OPUS 22 , Panel: NZ7

Principal investigator: prof. Joanna Mika

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Chronic pain in obesity: from cellular mechanisms to new strategies for targeted therapy.

Call: SONATA 17 , Panel: NZ5

Principal investigator: dr Anna Piotrowska-Murzyn

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

New 3-methoxypropanamide derivatives in search of effective substances for the treatment of neurological diseases - epil...

Call: PRELUDIUM 20 , Panel: NZ7

Principal investigator: Marcin Jakubiec

Uniwersytet Jagielloński, Collegium Medicum

Selective inhibitors of γ-aminobutyric acid (GABA) transporter subtype 3 (GAT3) as a new pharmacological tools and a cha...

Call: OPUS 21 , Panel: NZ7

Principal investigator: dr Dawid Panek

Uniwersytet Jagielloński, Collegium Medicum

Exploring new drug targets for efficacious therapy of neuropathic pain basing on the assessment and modulation of neuroi...

Call: OPUS 2 , Panel: NZ4

Principal investigator: dr hab. Joanna Mika

Instytut Farmakologii PAN

Dual histamine H3 and sigma-1 receptor ligands as novel pharmacological tools in the treatment of central nervous system...

Call: SONATINA 4 , Panel: NZ7

Principal investigator: Katarzyna Szczepańska

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Pharmacological modulation of histamine H3 and H4 receptors - a new perspective in the treatment of neuropathic pain

Call: SONATA 15 , Panel: NZ7

Principal investigator: dr Katarzyna Popiołek-Barczyk

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

New strategies in neuropathic pain pharmacotherapy based on the modulation of the functions of chemokine receptors CCR2 ...

Call: PRELUDIUM 15 , Panel: NZ7

Principal investigator: dr Klaudia Kwiatkowski

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Opioid-induced analgesia and hyperalgesia in neuropathic pain - mechanisms and druggable targets

Call: OPUS 15 , Panel: NZ7

Principal investigator: prof. Barbara Przewłocka

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Multifunctional ligands - TRPA1 channel antagonists and phosphodiesterases inhibitors as a new approach for the treatmen...

Call: OPUS 15 , Panel: NZ7

Principal investigator: dr hab. Grażyna Chłoń-Rzepa

Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

Novel hybrid compounds derived from pyrrolidine-2,5-dione or imidazolidine-2,4-dione scaffold and their effect on centra...

Call: OPUS 13 , Panel: NZ7

Principal investigator: dr hab. Krzysztof Kamiński

Uniwersytet Jagielloński Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

Determination of the mechanisms and potential targets for neuropathic pain therapy by investigating pharmacological inte...

Call: PRELUDIUM 12 , Panel: NZ7

Principal investigator: Anna Piotrowska-Murzyn

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

Search for new targets for an effective therapy of neuropathic pain and enhancement of opioids effects basing on the exa...

Call: OPUS 11 , Panel: NZ4

Principal investigator: prof. Joanna Mika

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk